PPP1R1B and Huntington disease: Administration of K6PC-5 in R6/2 mice was associated with increased levels of striatal DARPP-32 (Figure 4A), a specific marker of medium spiny neurons (Matamales et al., 2009), whose downregulation classically correlates with neurodegeneration in HD (Ehrlich, 2012).